Jazz Pharmaceuticals ( JAZZ +3.5% ) and its recent acquisition Gentium launch Defitelio (defibrotide) in Germany and Austria. The rollout will
Shares of Aria Pharmaceuticals ( ARIA ) are up 7% in premarket trading on rumors that Jazz Pharmaceuticals ( JAZZ ) is mulling a buyout for as much as $20/share versus yesterday's close of $7.60. This would value the acquisition
Barclays reinstates its coverage of Jazz Pharmaceuticals ( JAZZ ) with an Overweight rating and $200 price target. The target represents a 32% premium over today's price. Post your comment!
Associates (JKHY): Q3 EPS of $0.38 in-line. Revenue of $240M (+12% Y/Y) misses by $2M . ( PR ) Jazz Pharmaceuticals (JAZZ): Q1 EPS of $0.59 beats by $0.02 . Revenue of $51M (+45% Y/Y) in-line. Shares -0.38
Application to the FDA for the injection formula of FUSILEV, used to treat colorectal cancer (Jan. 2011). 4. Jazz Pharmaceuticals , Inc. (JAZZ): Market cap of $920.46M. Moving Averages: The stock is currently 4.28% above its 20